Alira Health’s Transformation Talks: Navigating the Vaccines’ Renaissance

The pandemic has revived interest in vaccines, but will this renaissance last forever? 

Multimedia
Category:
Published on:
December 16, 2021

Tune into this episode of “Transformation Talks” to learn more about the past, present, and future of the vaccine industry, from the lack of innovation for the last 20 years to new technologies like mRNA platforms and whole-cell vaccines. Our host Kenny Carberry, Associate Director of Clinical Development at Alira Health, and our expert in vaccines Bernd Schollmeier, VP of Global Market Access – Vaccines, will discuss the ups and downs of the vaccine industry, how the COVID pandemic has transformed it, and what is coming up next.

Follow us on LinkedIn to be the first one to sign up for our exclusive series of appointments with vaccine experts!

LISTEN TO THE EPISODE BELOW

Related news

Market Access
Publications December 3, 2021
White Paper: Enhancing Patient Access with Early Access Programs
Pharmaceutical companies are facing an increasing demand from physicians for Early Access Programs (EAPs) and are willing to make their innovative medicines available to patients with(...)
Market Access
Events November 24, 2021
Event: ISPOR Europe 2021
Join Alira Health experts at virtual ISPOR.
Market Access
Events November 9, 2021
Event: National Forum for Innovation in Health Sciences 2021
Join the Alira Health team at National Forum for Innovation in Health Sciences 2021 on November 17.
Market Access
Events November 2, 2021
Event: Eurobiomed: US Webinar Cycle: #2 Market Access & Regulatory Aspects
Join Alira Health's Director, Market Access, Pepi Hurtato, PhD, for an exclusive webinar session.
Market Access
Publications September 28, 2021
Alira Health Published in Business Development & Licensing Journal
Experts from the Alira Health team recently shared their thoughts regarding the importance of market access insights for the success of licensing operations with professionals from(...)
Digital Health Market Access
Publications April 20, 2021
Health Economics Evaluation and Value Proposition for an Antimicrobial Medical Device in the U.S. Market
A health economics evaluation assists companies during product development to better understand the product's impact across the ecosystem and position it appropriately.
Market Access MedTech
Multimedia February 26, 2021
Pricing in MedTech: Disentangling the Roles of Payers, DRGs, and Procurement
Join host Kenny Carberry, Associate Director of Clinical Development, Dan Legg, former Director of Clinical Sourcing at Guy’s & St Thomas at the St Thomas Hospital in London and CEO(...)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.